Department of Anatomy, Al-Mansoura University, Mansoura, Egypt.
Department of Anatomy, Taibah University, Medina, Saudi Arabia.
J Histochem Cytochem. 2018 Jan;66(1):33-45. doi: 10.1369/0022155417737484. Epub 2017 Oct 27.
In this study, we addressed the potential relationship between prominin-1 (prom1) and vascular endothelial growth factor (VEGFA) in diabetes-induced retinopathy. In total, we examined 28 retinas from 14 rats with streptozotocin-induced diabetes and 30 retinas from 15 untreated control rats. ELISA was used to measure the level of prom1 and VEGFA in retinal tissue homogenates. Immunohistochemical techniques were used with antibodies directed against prom1, VEGFA, and CASP-3. After 180 days of diabetes induction, we performed light and electron microscopy studies on rat eyes to evaluate histopathological changes and to estimate the de novo metric "Diabetic Retinopathy Histopathological Index" (DRHI). These changes were then correlated to the tissue and immunoexpression levels of prom1 and VEGFA. The data showed a significant upregulation of the tissue levels and optical densities (ODs) of VEGFA and prom1 immunoreactivity in diabetic retinas compared with controls. Both the tissue levels and OD values of prom1 and VEGFA correlated significantly with each other and to the diabetic structural changes as calculated by DRHI. Taken together, these data provide new insight into the potential role of prom1 and VEGFA in the development of diabetic retinopathy.
在这项研究中,我们研究了促泌素-1(prom1)和血管内皮生长因子(VEGFA)在糖尿病性视网膜病变中的潜在关系。总共检查了 14 只链脲佐菌素诱导糖尿病大鼠的 28 只视网膜和 15 只未处理对照大鼠的 30 只视网膜。酶联免疫吸附试验(ELISA)用于测量视网膜组织匀浆中 prom1 和 VEGFA 的水平。使用针对 prom1、VEGFA 和 CASP-3 的抗体进行免疫组织化学技术。在糖尿病诱导 180 天后,我们对大鼠眼睛进行了光镜和电镜研究,以评估组织病理学变化,并估计新的“糖尿病性视网膜病变组织病理学指数”(DRHI)。然后将这些变化与 prom1 和 VEGFA 的组织和免疫表达水平相关联。数据显示,与对照组相比,糖尿病视网膜中 VEGFA 和 prom1 免疫反应的组织水平和光密度(OD)显著上调。prom1 和 VEGFA 的组织水平和 OD 值均与彼此以及 DRHI 计算的糖尿病结构变化显著相关。总之,这些数据为 prom1 和 VEGFA 在糖尿病性视网膜病变发展中的潜在作用提供了新的见解。